Third Harmonic Bio, Inc.

NASDAQ (USD): Third Harmonic Bio, Inc. (THRD)

Last Price

12.15

Today's Change

-0.75 (5.81%)

Day's Change

12.00 - 13.06

Trading Volume

112,339

Overview

Market Cap

547 Million

Shares Outstanding

45 Million

Avg Volume

197,323

Avg Price (50 Days)

13.34

Avg Price (200 Days)

11.97

PE Ratio

-13.81

EPS

-0.88

Earnings Announcement

25-Mar-2025

Previous Close

12.90

Open

13.06

Day's Range

12.0 - 13.06

Year Range

6.4 - 16.94

Trading Volume

112,339

Price Change Highlight

1 Day Change

-5.81%

5 Day Change

-19.00%

1 Month Change

-11.12%

3 Month Change

4.29%

6 Month Change

-14.62%

Ytd Change

8.10%

1 Year Change

86.06%

3 Year Change

-28.53%

5 Year Change

-28.53%

10 Year Change

-28.53%

Max Change

-28.53%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment